APO Research, Inc.

APO RESEARCH · REPORT

Crisaborole

Selected research

Market Outlook & Growth Opportunities

Global Crisaborole Market Outlook and Growth Opportunities 2026

Market perspective

The global Crisaborole market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Crisaborole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Crisaborole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crisaborole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Crisaborole market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Crisaborole market include Neuraxpharm, Tapi Teva, VIRUJ PHARMA, Synergy Pharmaceutical and Ausun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Crisaborole market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Crisaborole and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Crisaborole sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Crisaborole market size, projected growth trends, production technologies, key applications, and end-use industries.

Crisaborole Segment by Company

Neuraxpharm

Tapi Teva

VIRUJ PHARMA

Synergy Pharmaceutical

Ausun Pharmaceutical

Crisaborole Segment by Type

Purity Above 98%

Purity Below 98%

Crisaborole Segment by Application

Allergic Dermatitis

Other

Crisaborole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Crisaborole status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Crisaborole market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Crisaborole significant trends, drivers, influence factors in global and regions.

6. To analyze Crisaborole competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crisaborole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crisaborole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crisaborole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Crisaborole market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Crisaborole industry.

Chapter 3: Detailed analysis of Crisaborole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Crisaborole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Crisaborole in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Crisaborole Industry Trends Table 2. Crisaborole Industry Drivers Table 3. Crisaborole Industry Opportunities and Challenges Table 4. Crisaborole Industry Restraints Table 5. Global Crisaborole Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Crisaborole Revenue Share by Company (2021-2026) Table 7. Global Crisaborole Sales Volume by Company (tons) & (2021-2026) Table 8. Global Crisaborole Sales Volume Share by Company (2021-2026) Table 9. Global Crisaborole Average Price (US$/kg) of Company (2021-2026) Table 10. Global Crisaborole Company Ranking, (2024-2026) & (USD Million) Table 11. Global Crisaborole Key Company Manufacturing Base & Headquarters Table 12. Global Crisaborole Company, Product Type & Application Table 13. Global Crisaborole Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Crisaborole by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity Above 98% Table 18. Significant Companies of Purity Below 98% Table 19. Global Crisaborole Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 20. Global Crisaborole Sales Volume by Type (2021-2026) & (tons) Table 21. Global Crisaborole Sales Volume by Type (2027-2032) & (tons) Table 22. Global Crisaborole Sales Volume Share by Type (2021-2026) Table 23. Global Crisaborole Sales Volume Share by Type (2027-2032) Table 24. Global Crisaborole Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Crisaborole Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Crisaborole Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Crisaborole Sales Value Share by Type (2021-2026) Table 28. Global Crisaborole Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Allergic Dermatitis Table 30. Significant Companies of Other Table 31. Global Crisaborole Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 32. Global Crisaborole Sales Volume by Application (2021-2026) & (tons) Table 33. Global Crisaborole Sales Volume by Application (2027-2032) & (tons) Table 34. Global Crisaborole Sales Volume Share by Application (2021-2026) Table 35. Global Crisaborole Sales Volume Share by Application (2027-2032) Table 36. Global Crisaborole Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Crisaborole Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Crisaborole Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Crisaborole Sales Value Share by Application (2021-2026) Table 40. Global Crisaborole Sales Value Share by Application (2027-2032) Table 41. Global Crisaborole Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 42. Global Crisaborole Sales by Region (2021-2026) & (tons) Table 43. Global Crisaborole Sales Market Share by Region (2021-2026) Table 44. Global Crisaborole Sales by Region (2027-2032) & (tons) Table 45. Global Crisaborole Sales Market Share by Region (2027-2032) Table 46. Global Crisaborole Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Crisaborole Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Crisaborole Sales Value Share by Region (2021-2026) Table 49. Global Crisaborole Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Crisaborole Sales Value Share by Region (2027-2032) Table 51. Global Crisaborole Market Average Price (US$/kg) by Region (2021-2026) Table 52. Global Crisaborole Market Average Price (US$/kg) by Region (2027-2032) Table 53. Global Crisaborole Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 54. Global Crisaborole Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Crisaborole Sales by Country (2021-2026) & (tons) Table 56. Global Crisaborole Sales Market Share by Country (2021-2026) Table 57. Global Crisaborole Sales by Country (2027-2032) & (tons) Table 58. Global Crisaborole Sales Market Share by Country (2027-2032) Table 59. Global Crisaborole Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Crisaborole Sales Value Market Share by Country (2021-2026) Table 61. Global Crisaborole Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Crisaborole Sales Value Market Share by Country (2027-2032) Table 63. Neuraxpharm Company Information Table 64. Neuraxpharm Business Overview Table 65. Neuraxpharm Crisaborole Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 66. Neuraxpharm Crisaborole Product Portfolio Table 67. Neuraxpharm Recent Development Table 68. Tapi Teva Company Information Table 69. Tapi Teva Business Overview Table 70. Tapi Teva Crisaborole Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 71. Tapi Teva Crisaborole Product Portfolio Table 72. Tapi Teva Recent Development Table 73. VIRUJ PHARMA Company Information Table 74. VIRUJ PHARMA Business Overview Table 75. VIRUJ PHARMA Crisaborole Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. VIRUJ PHARMA Crisaborole Product Portfolio Table 77. VIRUJ PHARMA Recent Development Table 78. Synergy Pharmaceutical Company Information Table 79. Synergy Pharmaceutical Business Overview Table 80. Synergy Pharmaceutical Crisaborole Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Synergy Pharmaceutical Crisaborole Product Portfolio Table 82. Synergy Pharmaceutical Recent Development Table 83. Ausun Pharmaceutical Company Information Table 84. Ausun Pharmaceutical Business Overview Table 85. Ausun Pharmaceutical Crisaborole Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Ausun Pharmaceutical Crisaborole Product Portfolio Table 87. Ausun Pharmaceutical Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Crisaborole Distributors List Table 91. Crisaborole Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Crisaborole Product Image Figure 2. Global Crisaborole Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crisaborole Sales Value (2021-2032) & (US$ Million) Figure 4. Global Crisaborole Sales (2021-2032) & (tons) Figure 5. Global Crisaborole Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Crisaborole Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity Above 98% Image Figure 10. Purity Below 98% Image Figure 11. Global Crisaborole Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 12. Global Crisaborole Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Crisaborole Sales Volume Share by Type (2021-2032) Figure 14. Global Crisaborole Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Crisaborole Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Crisaborole Sales Value Share by Type (2021-2032) Figure 17. Allergic Dermatitis Image Figure 18. Other Image Figure 19. Global Crisaborole Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 20. Global Crisaborole Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Crisaborole Sales Volume Share by Application (2021-2032) Figure 22. Global Crisaborole Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Crisaborole Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Crisaborole Sales Value Share by Application (2021-2032) Figure 25. Global Crisaborole Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 26. Global Crisaborole Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Crisaborole Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Crisaborole Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Crisaborole Sales Value (2021-2032) & (US$ Million) Figure 30. North America Crisaborole Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Crisaborole Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Crisaborole Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Crisaborole Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Crisaborole Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Crisaborole Sales Value (2021-2032) & (US$ Million) Figure 36. South America Crisaborole Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Crisaborole Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Crisaborole Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Crisaborole Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Crisaborole Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Crisaborole Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Crisaborole Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Crisaborole Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Purity Above 98%
  • Purity Below 98%
Applications
  • Allergic Dermatitis
  • Other
Companies covered
  • Neuraxpharm
  • Tapi Teva
  • VIRUJ PHARMA
  • Synergy Pharmaceutical
  • Ausun Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Crisaborole Sales Value (2021-2032)
  4. 1.2.2 Global Crisaborole Sales Volume (2021-2032)
  5. 1.2.3 Global Crisaborole Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Crisaborole Market Dynamics
  1. 2.1 Crisaborole Industry Trends
  2. 2.2 Crisaborole Industry Drivers
  3. 2.3 Crisaborole Industry Opportunities and Challenges
  4. 2.4 Crisaborole Industry Restraints
3 Crisaborole Market by Company
  1. 3.1 Global Crisaborole Company Revenue Ranking in 2025
  2. 3.2 Global Crisaborole Revenue by Company (2021-2026)
  3. 3.3 Global Crisaborole Sales Volume by Company (2021-2026)
  4. 3.4 Global Crisaborole Average Price by Company (2021-2026)
  5. 3.5 Global Crisaborole Company Ranking (2024-2026)
  6. 3.6 Global Crisaborole Company Manufacturing Base and Headquarters
  7. 3.7 Global Crisaborole Company Product Type and Application
  8. 3.8 Global Crisaborole Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Crisaborole Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Crisaborole Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Crisaborole Market by Type
  1. 4.1 Crisaborole Type Introduction
  2. 4.1.1 Purity Above 98%
  3. 4.1.2 Purity Below 98%
  4. 4.2 Global Crisaborole Sales Volume by Type
  5. 4.2.1 Global Crisaborole Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Crisaborole Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Crisaborole Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Crisaborole Sales Value by Type
  9. 4.3.1 Global Crisaborole Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Crisaborole Sales Value by Type (2021-2032)
  11. 4.3.3 Global Crisaborole Sales Value Share by Type (2021-2032)
5 Crisaborole Market by Application
  1. 5.1 Crisaborole Application Introduction
  2. 5.1.1 Allergic Dermatitis
  3. 5.1.2 Other
  4. 5.2 Global Crisaborole Sales Volume by Application
  5. 5.2.1 Global Crisaborole Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Crisaborole Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Crisaborole Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Crisaborole Sales Value by Application
  9. 5.3.1 Global Crisaborole Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Crisaborole Sales Value by Application (2021-2032)
  11. 5.3.3 Global Crisaborole Sales Value Share by Application (2021-2032)
6 Crisaborole Regional Sales and Value Analysis
  1. 6.1 Global Crisaborole Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Crisaborole Sales by Region (2021-2032)
  3. 6.2.1 Global Crisaborole Sales by Region: 2021-2026
  4. 6.2.2 Global Crisaborole Sales by Region (2027-2032)
  5. 6.3 Global Crisaborole Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Crisaborole Sales Value by Region (2021-2032)
  7. 6.4.1 Global Crisaborole Sales Value by Region: 2021-2026
  8. 6.4.2 Global Crisaborole Sales Value by Region (2027-2032)
  9. 6.5 Global Crisaborole Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Crisaborole Sales Value (2021-2032)
  12. 6.6.2 North America Crisaborole Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Crisaborole Sales Value (2021-2032)
  15. 6.7.2 Europe Crisaborole Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Crisaborole Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Crisaborole Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Crisaborole Sales Value (2021-2032)
  21. 6.9.2 South America Crisaborole Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Crisaborole Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Crisaborole Sales Value Share by Country, 2025 VS 2032
7 Crisaborole Country-level Sales and Value Analysis
  1. 7.1 Global Crisaborole Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Crisaborole Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Crisaborole Sales by Country (2021-2032)
  4. 7.3.1 Global Crisaborole Sales by Country (2021-2026)
  5. 7.3.2 Global Crisaborole Sales by Country (2027-2032)
  6. 7.4 Global Crisaborole Sales Value by Country (2021-2032)
  7. 7.4.1 Global Crisaborole Sales Value by Country (2021-2026)
  8. 7.4.2 Global Crisaborole Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Crisaborole Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Crisaborole Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Crisaborole Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Crisaborole Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Crisaborole Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Crisaborole Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Crisaborole Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Crisaborole Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Crisaborole Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Crisaborole Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Crisaborole Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Crisaborole Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Crisaborole Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Crisaborole Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Crisaborole Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Crisaborole Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Crisaborole Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Crisaborole Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Crisaborole Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Crisaborole Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Crisaborole Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Crisaborole Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Crisaborole Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Crisaborole Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Crisaborole Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Crisaborole Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Crisaborole Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Crisaborole Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Crisaborole Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Crisaborole Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Crisaborole Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Crisaborole Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Crisaborole Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Crisaborole Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Crisaborole Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Crisaborole Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Crisaborole Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Crisaborole Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Crisaborole Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Crisaborole Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Crisaborole Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Crisaborole Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Crisaborole Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Crisaborole Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Crisaborole Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Crisaborole Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Crisaborole Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Crisaborole Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Crisaborole Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Crisaborole Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Crisaborole Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Crisaborole Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Crisaborole Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Crisaborole Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Crisaborole Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Crisaborole Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Crisaborole Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Crisaborole Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Crisaborole Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Crisaborole Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Crisaborole Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Crisaborole Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Crisaborole Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Crisaborole Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Crisaborole Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Crisaborole Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Crisaborole Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Crisaborole Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Crisaborole Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Crisaborole Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Crisaborole Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Crisaborole Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Crisaborole Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Crisaborole Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Crisaborole Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Crisaborole Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Crisaborole Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Crisaborole Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Crisaborole Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Crisaborole Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Crisaborole Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Crisaborole Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Crisaborole Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Crisaborole Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Neuraxpharm
  2. 8.1.1 Neuraxpharm Company Information
  3. 8.1.2 Neuraxpharm Business Overview
  4. 8.1.3 Neuraxpharm Crisaborole Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Neuraxpharm Crisaborole Product Portfolio
  6. 8.1.5 Neuraxpharm Recent Developments
  7. 8.2 Tapi Teva
  8. 8.2.1 Tapi Teva Company Information
  9. 8.2.2 Tapi Teva Business Overview
  10. 8.2.3 Tapi Teva Crisaborole Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tapi Teva Crisaborole Product Portfolio
  12. 8.2.5 Tapi Teva Recent Developments
  13. 8.3 VIRUJ PHARMA
  14. 8.3.1 VIRUJ PHARMA Company Information
  15. 8.3.2 VIRUJ PHARMA Business Overview
  16. 8.3.3 VIRUJ PHARMA Crisaborole Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 VIRUJ PHARMA Crisaborole Product Portfolio
  18. 8.3.5 VIRUJ PHARMA Recent Developments
  19. 8.4 Synergy Pharmaceutical
  20. 8.4.1 Synergy Pharmaceutical Company Information
  21. 8.4.2 Synergy Pharmaceutical Business Overview
  22. 8.4.3 Synergy Pharmaceutical Crisaborole Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Synergy Pharmaceutical Crisaborole Product Portfolio
  24. 8.4.5 Synergy Pharmaceutical Recent Developments
  25. 8.5 Ausun Pharmaceutical
  26. 8.5.1 Ausun Pharmaceutical Company Information
  27. 8.5.2 Ausun Pharmaceutical Business Overview
  28. 8.5.3 Ausun Pharmaceutical Crisaborole Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ausun Pharmaceutical Crisaborole Product Portfolio
  30. 8.5.5 Ausun Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Crisaborole Value Chain Analysis
  2. 9.1.1 Crisaborole Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Crisaborole Sales Mode & Process
  6. 9.2 Crisaborole Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Crisaborole Distributors
  9. 9.2.3 Crisaborole Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.